Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population

被引:0
|
作者
Mateusz Siedlinski
Dirkje S Postma
Jolanda MA Boer
Gerrit van der Steege
Jan P Schouten
Henriette A Smit
H Marike Boezen
机构
[1] University Medical Center Groningen,Department of Epidemiology
[2] University of Groningen,Department of Pulmonology
[3] University Medical Center Groningen,Department of Medical Genetics
[4] University of Groningen,undefined
[5] National Institute for Public Health and the Environment,undefined
[6] University Medical Center Groningen,undefined
[7] University of Groningen,undefined
来源
关键词
Chronic Obstructive Pulmonary Disease; Complete Linkage Disequilibrium; Chronic Obstructive Pulmonary Disease Subject; Dutch Cohort; Pool Cohort;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population
    Siedlinski, Mateusz
    Postma, Dirkje S.
    Boer, Jolanda M. A.
    van der Steege, Gerrit
    Schouten, Jan P.
    Smit, Henriette A.
    Boezen, H. Marike
    RESPIRATORY RESEARCH, 2009, 10
  • [2] KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
    Arolt, Christoph
    Dugan, Margaret
    Wild, Robert
    Richartz, Vanessa
    Holz, Barbara
    Scheel, Andreas H.
    Braegelmann, Johannes
    Wagener-Ryczek, Svenja
    Merkelbach-Bruse, Sabine
    Wolf, Juergen
    Buettner, Reinhard
    Catanzariti, Luigi
    Fler, Matthias Schef
    Hillmer, Axel M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : 1550 - 1567
  • [3] Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy
    Liu, Zhou
    Yin, Xiaojian
    Liu, Lingying
    Tao, Hua
    Zhou, Haihong
    Ma, Guoda
    Cui, Lili
    Li, You
    Zhang, Shuyan
    Xu, Zhi'en
    Yao, LiFen
    Cai, Zhiyou
    Zhao, Bin
    Li, Keshen
    GENE, 2015, 571 (02) : 231 - 236
  • [4] Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis
    Bergstrom, Petra
    von Otter, Malin
    Nilsson, Staffan
    Nilsson, Ann-Charloth
    Nilsson, Michael
    Andersen, Peter M.
    Hammarsten, Ola
    Zetterberg, Henrik
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (1-2) : 130 - 137
  • [5] NFE2L2 polymorphisms, mortality, and metabolism in the general population
    Figarska, Sylwia M.
    Vonk, Judith M.
    Boezen, H. Marike
    PHYSIOLOGICAL GENOMICS, 2014, 46 (12) : 411 - 417
  • [6] KEAP1/NRF2 (NFE2L2) mutations in NSCLC-Fuel for a superresistant phenotype?
    Dempke, Wolfram C. M.
    Reck, Martin
    LUNG CANCER, 2021, 159 : 10 - 17
  • [7] Genetic landscape of KEAP1 and NFE2L2 mutated cancers from the AACR GENIE database
    Zaki, M.
    Pahalyants, V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] CANCER RELATED METHYLATION IN KEAP1 ACTIVATE NFE2L2 ACTIVITY AND PROMOTE MALIGNANCY OF CERVICAL CANCER
    Hasimu, A.
    Ma, J.
    Mamtimin, B.
    Yimiti, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 810 - 810
  • [9] Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
    Jin, Xing
    Zheng, Yuansheng
    Chen, Zhencong
    Wang, Fei
    Bi, Guoshu
    Li, Ming
    Liang, Jiaqi
    Sui, Qihai
    Bian, Yunyi
    Hu, Zhengyang
    Qiao, Yulei
    Xu, Songtao
    CANCER MEDICINE, 2021, 10 (23): : 8673 - 8692
  • [10] Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
    Paik, Paul K.
    Fan, Pang-Dian
    Qeriqi, Besnik
    Namakydoust, Azadeh
    Daly, Bobby
    Ahn, Linda
    Kim, Rachel
    Plodkowski, Andrew
    Ni, Ai
    Chang, Jason
    Fanaroff, Rachel
    Ladanyi, Marc
    de Stanchina, Elisa
    Rudin, Charles M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : 516 - 526